Searched for
BIOPHARMA HUB
Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...- Govt outlines next phase of pharma growthThe government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- India steers boat through a risky channel between war clouds and El NinoIndia faces a challenging global economic outlook for 2026-27. Geopolitical tensions and volatile oil prices are key concerns. However, Ind...
- India Pharma 2026 event: Nadda lays out road map for India to take global pharma leadership roleIndia Pharma Conference: India is set to become a global leader in advanced medicines like biologics and biosimilars, Union Minister J P Na...
- FM Nirmala Sitharaman to push biopharma, semiconductor missions in NorwayFinance Minister Nirmala Sitharaman is in Oslo to boost India's bio-pharma and semiconductor sectors. She will meet Norwegian Prime Ministe...
- Biocon's Shaw says Budget boosts India’s health and innovation agendaThe Union Budget is making a significant investment in India's health and innovation. Biopharma has been identified as a key strategic sect...
- Budget 2026 gives biologics & biosimilars a major policy boostIndia is set to become a global biopharmaceutical manufacturing hub. Finance Minister Nirmala Sitharaman announced a dedicated ₹10,000 cror...
- Budget 2026: Sitharaman launches 'Biopharma Shakti' with a Rs 10,000-crore bet to heal India, power manufacturingUnion Budget 2026: With the announcement of the 'Biopharma Shakti' initiative, India is gearing up to take the world stage in biopharmaceut...
- Budget 2026: Max Healthcare, Apollo Hospitals, other stocks rise up to 4% as FM boosts medical tourismIndian healthcare stocks surged following the Union Budget 2026 announcement of measures to boost medical tourism. The government plans to ...
- Budget 2026: Finance Minister proposes 5 medical tourism hubsFinance Minister Nirmala Sitharaman announced plans for five regional medical tourism hubs. A Rs 10,000 crore Biopharma Shakti program will...
- Budget 2026: Sitharaman proposes Rs 10,000-crore Biopharma Shakti scheme to boost biopharma manufacturingThe proposed fund aims to position India as a global biopharma manufacturing hub
- Budget 2026: Sitharaman’s six-point plan to propel India’s next growth phaseUnion Budget 2026: Finance Minister Nirmala Sitharaman has presented a six-point plan to boost India's economy. The strategy prioritizes ma...
- Telangana plans country’s first biopharma hubTelangana government proposes to set up India’s first Biopharma-Hub to provide support to the biopharma research and development activities.
- Time for India to be innovator nation in bio-pharmaceuticals: Expert"India has a strong potential to become a hub for bio-pharma innovation and play a leading role in collaborative research for the same."
- Time for India to be innovator nation in bio-pharma: ExpertThis will have a huge economic impact creating high paying jobs, intellectual property and the real possibility for India to play a leading...
- Strides arm commences construction of $ 60-million Malaysia plantStelis Biopharma, wholly-owned arm of Strides Arcolab, has commenced construction of its Rs 370 crore (USD 60 million) biologics facility a...
- India needs to step up to be a biopharma major, says Boston Consulting Group"India offers several advantages in R&D, but it's behind," said Bart Janssens, a BCG partner and coauthor of the report.
- 'India has potential to be global hub of bio-pharma sector'Noting that India has the ability to be a "global hub" in the bio-pharma and healthcare sector, industry leaders have said that steps need ...
- India can become innovation hub for bio-pharma: BCG reportEmerging markets will drive 70% of growth in the pharma industry and India will require supportive policies to leverage the BioPharma.
Load More
